[1]刘殿菊.天津市滨海新区接种手足口病疫苗前后 流行病学特征对照分析[J].医学信息,2019,32(12):133-135.[doi:10.3969/j.issn.1006-1959.2019.12.043]
 LIU Dian-ju.Comparative Analysis of Epidemiological Characteristics of Hand Foot Mouth Disease Vaccine Before and After Inoculation in Tianjin Binhai New Area[J].Journal of Medical Information,2019,32(12):133-135.[doi:10.3969/j.issn.1006-1959.2019.12.043]
点击复制

天津市滨海新区接种手足口病疫苗前后 流行病学特征对照分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年12期
页码:
133-135
栏目:
调查分析
出版日期:
2019-06-15

文章信息/Info

Title:
Comparative Analysis of Epidemiological Characteristics of Hand Foot Mouth Disease Vaccine Before and After Inoculation in Tianjin Binhai New Area
文章编号:
1006-1959(2019)12-0133-03
作者:
刘殿菊
天津市滨海新区塘沽传染病医院传染科,天津 300454
Author(s):
LIU Dian-ju
Department of Infectious Diseases,Tanggu Infectious Disease Hospital,Binhai New Area,Tianjin 300454,China
关键词:
天津市滨海新区手足口病接种疫苗流行病学
Keywords:
Key words:Tianjin Binhai New AreaHand Foot and Mouth DiseaseVaccinationEpidemiology
分类号:
R725.1
DOI:
10.3969/j.issn.1006-1959.2019.12.043
文献标志码:
A
摘要:
目的 对天津市滨海新区2017年接种手足口病疫苗前后各一年流行病学特征进行对照分析,为手足口病预防控制提供有力依据。方法 我院于2017年4月1日开始接种肠道病毒71型灭活疫苗,收集2016年4月1日~2018年4月1日我院门诊就诊的手足口病患者共1237例,其中接种疫苗前一年796例,接种疫苗后一年441例。采用描述性流行病学研究方法,对比接种手足口病疫苗前后各一年的流行病学特征。结果 我院接种手足口病疫苗后一年较前一年发生率下降,从年龄分布看出,接种疫苗前后各年龄组均有发病,发病均以5岁以下儿童为主,其中接种疫苗前一年占83.17%,接种疫苗后一年占81.18%,接种疫苗前一年均高于接种疫苗后一年。从职业分布看出,接种疫苗前后各职业组均有发病,发病均以幼托儿童为主,其中接种疫苗前一年占全年52.64%,接种疫苗后一年占全年46.26%,接种疫苗前一年均高于接种疫苗后一年。从时间分布看出,接种疫苗前一年与接种疫苗后一年手足口病发病时间均有明显的季节性特征,高峰期主要为7月份,其次为6月份。接种疫苗前一年6月份占29.52%,7月份占29.90%,接种疫苗后一年6月份占20.18%,7月份占23.81%,接种疫苗前一年均高于接种疫苗后一年。结论 接种手足口病疫苗是降低手足口病发生率最有效方法。
Abstract:
Abstract:Objective To analyze the epidemiological characteristics of the hand foot mouth disease vaccine in Tianjin Binhai New Area in 2017, and provide a strong basis for prevention and control of hand foot and mouth disease. Methods Our hospital began to inoculate enterovirus 71 inactivated vaccine on April 1, 2017, and collected 1237 cases of hand, foot and mouth disease patients from our hospital from April 1, 2016 to April 1, 2018, including vaccination. There were 796 cases in the year before the vaccine and 441 cases in the year after the vaccination. Descriptive epidemiological studies were used to compare the epidemiological characteristics of the year before and after the vaccine for hand foot and mouth disease. Results The incidence of hand foot and mouth disease vaccine in our hospital decreased from one year to the previous year. From the age distribution, all age groups before and after vaccination had morbidity, and the incidence was mainly children under 5 years old. It accounts for 83.17% of the year and 81.18% of the year after vaccination. The year before vaccination is higher than one year after vaccination. From the occupational distribution, the occupational groups were vaccinated before and after vaccination, and the incidence was mainly children's children, including 52.64% of the year before vaccination and 46.26% of the year after vaccination. The previous year was higher than one year after vaccination. From the time distribution, there was a clear seasonal characteristic of the incidence of hand, foot and mouth disease in the year before vaccination and one year after vaccination. The peak period was mainly in July, followed by June. Before the vaccination, it accounted for 29.52% in June, 29.90% in July, 20.18% in June after vaccination, and 23.81% in July. The year before vaccination was higher than one year after vaccination. Conclusion Vaccination of hand, foot and mouth disease vaccine is the most effective way to reduce the incidence of hand foot and mouth disease.

参考文献/References:

[1]Crawford NW,Graham SM.EV71 vaccine:protection from a previously neglected disease[J].Lancet,2013,381(9882):1968-1970. [2]国家卫生健康委员会.手足口病诊疗指南[J].传染病信息,2018,31(3):193-198. [3]徐敬,陆敏樱,童琦,等.小儿手足口病的流行病学特征及预防[J].中国卫生标准管理,2015,6(5):16-17. [4]Li R,Liu L,Mo Z,et al.An inactivated enterovirus 71 vaccine in healthy children[J].N Engl J Med,2014,370(9):829-837. [5]Yi E,Shin Y,Kim J,et al.Enterovirus 71 infection and vaccines[J].Clin Exp Vaccine Res,2017,6(1):4-14. [6]高丽,陈爱女,赖耀荣,等.2016年浙江省象山县5岁及以下幼儿家长手足口病认知和EV71疫苗接种意愿调查[J].实用预防医学,2018,25(4):474-477. [7]李红霞,张文增,陈东妮,等.北京市顺义区5岁以下婴幼儿家长手足口病认知情况与EV71疫苗接种意愿调查[J].公共卫生与预防医学,2016,27(5):25-28. [8]孙倩莱,高立冬,胡世雄,等.2009-2015年湖南省手足口病死亡病例临床与流行病学特征分析[J].实用预防医学,2017,24(2):148-151. [9]谢皆强.儿童接种手足口疫苗对手足口病的预防效果及安全性分析[J].中西医结合心血管病杂志,2017,5(36):50,52. [10]Mao Q,Wang Y,Bian L,et al.EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases[J].Emerg Microbes Infect,2016,20,5(7):e75.

相似文献/References:

[1]覃 艺,邓燕艺,赖昌生,等.手足口病患儿体内免疫球蛋白、补体、C反应蛋白及刺激分析CD80、CD86水平的临床意义及其与丙种球蛋白治疗疗效的关系[J].医学信息,2018,31(02):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
 Qin Yi,DENG Yan-yi,LAI Chang-sheng,et al.Clinical Significance of Immunoglobulin,Complement,C-reactive Protein and CD80,CD86 in Children with Hand-foot-mouth Disease and their Relationship with Therapeutic Effect of Gamma Globulin[J].Journal of Medical Information,2018,31(12):63.[doi:10.3969/j.issn.1006-1959.2018.02.022]
[2]李 淼,孙浩淼,纵书芳,等.徐州地区2015~2016年手足口病流行病学特征分析[J].医学信息,2018,31(02):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
 LI Miao,SUN Hao-miao,ZONG Shu-fang,et al.Epidemiological Characteristics of Hand-foot-mouth Disease in Xuzhou Area in 2015 to 2016[J].Journal of Medical Information,2018,31(12):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
[3]任燕.手足口病患儿血清淋巴细胞免疫分型的水平变化及临床意义[J].医学信息,2018,31(01):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
 REN Yan.Serum Level of Lymphocyte Immunophenotype in Children with Hand-foot-mouth Disease and its Clinical Significance[J].Journal of Medical Information,2018,31(12):82.[doi:10.3969/j.issn.1006-1959.2018.01.029]
[4]覃 艺,邓燕艺,赖昌生,等.554例儿童重症手足口病的临床特征分析[J].医学信息,2018,31(11):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
 QIN Yi,DENG Yan-yi,LAI Chang-sheng,et al.Analysis of Clinical Features of Severe Hand Foot and Mouth Disease in 554 Children[J].Journal of Medical Information,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.11.036]
[5]兰文林,白宝鑫,石武祥.手足口病研究进展及防治措施[J].医学信息,2018,31(15):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
 LAN Wen-lin,BAO Bao-xin,SHI Wu-xiang.Research Progress and Control Measures of Hand-Foot-Mouth Disease[J].Journal of Medical Information,2018,31(12):29.[doi:10.3969/j.issn.1006-1959.2018.15.011]
[6]刘 娜,闫卫利.2016年我院儿童病院肠道病毒71型感染情况调查[J].医学信息,2018,31(15):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
 LIU Na,YAN Wei-li.Investigation of Human Enterovirus 71 Infection in our Children's Hospital in 2016[J].Journal of Medical Information,2018,31(12):115.[doi:10.3969/j.issn.1006-1959.2018.15.036]
[7]管 建,姜娟娟.血清IL-6、IL-10、CRP和PCT水平检测对手足口病早期 合并细菌感染患儿的临床诊断价值[J].医学信息,2018,31(15):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
 GUAN Jian,JIANG Juan-juan.Clinical Diagnostic Value of Serum Levels of IL-6,IL-10,CRP and PCT in Children with Hand-Foot-and-Mouth Disease Combined with Early Bacterial Infection[J].Journal of Medical Information,2018,31(12):146.[doi:10.3969/j.issn.1006-1959.2018.15.047]
[8]李正兰.重组人干扰素α1b治疗小儿手足口病的临床疗效观察[J].医学信息,2019,32(05):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
 LI Zheng-lan.Clinical Observation of Recombinant Human Interferon α1b in the Treatment of Hand-Foot-Mouth Disease in Children[J].Journal of Medical Information,2019,32(12):156.[doi:10.3969/j.issn.1006-1959.2019.05.050]
[9]陆志刚,梁 洁,钟 敏.新疆第八师石河子市2015~2018年手足口病原学特征及病流行病学分析[J].医学信息,2019,32(06):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]
 LU Zhi-gang,LIANG Jie,ZHONG Min.Epidemiological Characteristics and Epidemiological Analysis of Hand,Foot and Mouth in Shihezi City,the Eighth Division of Xinjiang from 2015 to 2018[J].Journal of Medical Information,2019,32(12):82.[doi:10.3969/j.issn.1006-1959.2019.06.026]
[10]张小华,敏 峰,张玲丽.喜炎平联合单磷酸阿糖腺苷治疗小儿手足口病的 效果及安全性[J].医学信息,2019,32(15):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]
 ZHANG Xiao-hua,MIN Feng,ZHANG Ling-li.Application Effect and Safety of Xiyanping Combined with Adenosine Monophosphate in the Treatment of Hand,Foot and Mouth Disease in Children[J].Journal of Medical Information,2019,32(12):157.[doi:10.3969/j.issn.1006-1959.2019.15.052]

更新日期/Last Update: 2019-06-15